Get the Stockscreener App
2.68
17.54%
0.40
After Hours:
2.62
-0.06
-2.24%
Novabay Pharmaceuticals Inc stock is traded at $2.68, with a volume of 5.47M.
It is up +17.54% in the last 24 hours and up +351.56% over the past month.
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$2.28
Open:
$2.5
24h Volume:
5.47M
Relative Volume:
0.98
Market Cap:
$15.61M
Revenue:
$14.64M
Net Income/Loss:
$-13.74M
P/E Ratio:
-0.3686
EPS:
-7.27
Net Cash Flow:
$-5.04M
1W Performance:
+72.90%
1M Performance:
+351.56%
6M Performance:
+361.51%
1Y Performance:
+453.03%
1-Day Range:
$2.33
$2.71
1-Week Range:
$1.45
$2.71
52-Week Range:
$0.44
$2.71
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Name
Novabay Pharmaceuticals Inc
Sector
Industry
Phone
510-899-8800
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
2.68 | 13.28M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-19 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Reiterated | Laidlaw | Buy |
| Jun-05-17 | Initiated | ROTH Capital | Buy |
| Mar-27-17 | Initiated | Laidlaw | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-07-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-14-15 | Reiterated | Maxim Group | Buy |
| Apr-30-15 | Resumed | Maxim Group | Buy |
| Mar-06-13 | Initiated | Ascendiant Capital Markets | Strong Buy |
| Jan-03-08 | Initiated | Dawson James | Speculative Buy |
View All
Novabay Pharmaceuticals Inc Stock (NBY) Latest News
NovaBay Pharma Appoints New CEO Amid Strategic Shift - MSN
Intraday pattern recognizer results for NovaBay Pharmaceuticals Inc.2025 Sector Review & Technical Confirmation Trade Alerts - Newser
What is NovaBay Pharmaceuticals Inc. s revenue forecastRate Hike & Community Trade Idea Sharing Platform - khodrobank.com
Using AI based signals to follow NovaBay Pharmaceuticals Inc.Analyst Downgrade & Safe Entry Zone Identification - Newser
NovaBay Pharmaceuticals Inc. stock chart pattern explainedEarnings Miss & AI Forecast Swing Trade Picks - Newser
What are NovaBay Pharmaceuticals Inc.’s earnings expectationsTrade Signal Summary & Fast Gain Stock Tips - khodrobank.com
Why Did Novabay Stock Soar 19.3%? - AInvest
How to build a custom watchlist for NovaBay Pharmaceuticals Inc.2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Tick level data insight on NovaBay Pharmaceuticals Inc. volatilityMarket Weekly Review & Daily Entry Point Alerts - Newser
Real time alert setup for NovaBay Pharmaceuticals Inc. performance2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - Newser
Advanced analytics toolkit walkthrough for NovaBay Pharmaceuticals Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - Newser
Will NovaBay Pharmaceuticals Inc. stock recover after recent drop2025 Top Gainers & Expert Curated Trade Setups - Newser
Forecasting NovaBay Pharmaceuticals Inc. price range with options dataJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Is NovaBay Pharmaceuticals Inc. still worth holding after the dipSell Signal & Fast Exit and Entry Strategy Plans - Newser
Tools to monitor NovaBay Pharmaceuticals Inc. recovery probabilityDividend Hike & Safe Capital Growth Tips - Newser
Is NovaBay Pharmaceuticals Inc. a turnaround story2025 Momentum Check & Free High Return Stock Watch Alerts - khodrobank.com
Using economic indicators to assess NovaBay Pharmaceuticals Inc. potentialWeekly Stock Summary & Technical Buy Zone Confirmations - Newser
Is NovaBay Pharmaceuticals Inc. a candidate for recovery playPortfolio Return Report & Low Drawdown Trading Strategies - Newser
What technical models suggest about NovaBay Pharmaceuticals Inc.’s comebackMarket Growth Review & Safe Swing Trade Setups - Newser
How to recover losses in NovaBay Pharmaceuticals Inc. stockMarket Trend Review & Community Shared Stock Ideas - Newser
What recovery options are there for NovaBay Pharmaceuticals Inc.Sell Signal & Free Safe Capital Growth Stock Tips - Newser
Live market analysis of NovaBay Pharmaceuticals Inc.Quarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
Chart based exit strategy for NovaBay Pharmaceuticals Inc.Weekly Trend Summary & Fast Moving Trade Plans - Newser
Can NovaBay Pharmaceuticals Inc. hit a new high this monthPortfolio Update Report & Daily Profit Focused Stock Screening - Newser
What are NovaBay Pharmaceuticals Inc.’s recent SEC filings showingQuarterly Investment Review & Accurate Intraday Trading Signals - khodrobank.com
Can NovaBay Pharmaceuticals Inc. lead its sector in growth2025 Stock Rankings & Risk Managed Investment Signals - خودرو بانک
How moving averages guide NovaBay Pharmaceuticals Inc. trading2025 Market Outlook & AI Driven Stock Movement Reports - Newser
What is NovaBay Pharmaceuticals Inc. s debt to equity ratioJuly 2025 Update & Real-Time Market Trend Scan - khodrobank.com
NovaBay Stock: A Wild Ride or Solid Bet? - StocksToTrade
What’s the recovery path for long term holders of NovaBay Pharmaceuticals Inc.2025 Major Catalysts & Capital Efficiency Focused Strategies - Newser
Novabay Pharmaceuticals Soars 11.8% on New CEO Appointment - AInvest
What to do if you’re stuck in NovaBay Pharmaceuticals Inc.July 2025 EndofMonth & Real-Time Sentiment Analysis - Newser
Is NovaBay Pharmaceuticals Inc. stock good for income investorsMarket Performance Summary & Low Risk Profit Maximizing Plans - khodrobank.com
Can NovaBay Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Fed Impact & High Return Trade Opportunity Guides - khodrobank.com
How does NovaBay Pharmaceuticals Inc. correlate with NasdaqJuly 2025 Highlights & Real-Time Volume Surge Alerts - khodrobank.com
Options Flow: Is NovaBay Pharmaceuticals Inc. stock good for income investorsMarket Performance Recap & Daily Price Action Insights - khodrobank.com
NovaBay Pharmaceuticals Inc. Approaches Psychological Resistance LevelProfit Target & Stock Market Timing Techniques - beatles.ru
Published on: 2025-09-01 20:13:56 - khodrobank.com
What the charts say about NovaBay Pharmaceuticals Inc. todayWeekly Loss Report & Accurate Intraday Trading Signals - Newser
Novabay Pharmaceuticals Inc Stock (NBY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):